Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®

Multi-gene prognostic signatures including the Oncotype® DX Recurrence Score (RS), EndoPredict® (EP) and Prosigna® (Risk Of Recurrence, ROR) are widely used to predict the likelihood of distant recurrence in patients with oestrogen-receptor-positive (ER+), HER2-negative breast cancer. Here, we descr...

Descripción completa

Detalles Bibliográficos
Autores principales: Buus, Richard, Szijgyarto, Zsolt, Schuster, Eugene F., Xiao, Hui, Haynes, Ben P., Sestak, Ivana, Cuzick, Jack, Paré, Laia, Seguí, Elia, Chic, Nuria, Prat, Aleix, Dowsett, Mitch, Cheang, Maggie Chon U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881187/
https://www.ncbi.nlm.nih.gov/pubmed/33579961
http://dx.doi.org/10.1038/s41523-021-00216-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881187/
https://www.ncbi.nlm.nih.gov/pubmed/33579961
http://dx.doi.org/10.1038/s41523-021-00216-w

Ejemplares similares